Masashi Ando

4.8k total citations
206 papers, 3.6k citations indexed

About

Masashi Ando is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Masashi Ando has authored 206 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 75 papers in Pulmonary and Respiratory Medicine and 49 papers in Surgery. Recurrent topics in Masashi Ando's work include Gastric Cancer Management and Outcomes (31 papers), Breast Cancer Treatment Studies (29 papers) and Cancer Treatment and Pharmacology (29 papers). Masashi Ando is often cited by papers focused on Gastric Cancer Management and Outcomes (31 papers), Breast Cancer Treatment Studies (29 papers) and Cancer Treatment and Pharmacology (29 papers). Masashi Ando collaborates with scholars based in Japan, United States and United Kingdom. Masashi Ando's co-authors include Yasuhiro Fujiwara, Noriyuki Katsumata, Kan Yonemori, Kenji Tamura, Chikako Shimizu, Toru Watanabe, Takayuki Kinoshita, Mayu Yunokawa, Tsutomu Kouno and Masaru Narabayashi and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Masashi Ando

190 papers receiving 3.5k citations

Peers

Countries citing papers authored by Masashi Ando

Since Specialization

Citations

This map shows the geographic impact of Masashi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Ando more than expected).

Fields of papers citing papers by Masashi Ando

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Ando. The network helps show where Masashi Ando may publish in the future.

Co-authorship network of co-authors of Masashi Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Ando. A scholar is included among the top collaborators of Masashi Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Ando. Masashi Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510) 2024 ·Cancer ·Tadaaki Nishikawa, Shigeki Kakunaga, Kenji Tamura, Masashi Ando, Toshifumi Ozaki, Akira Kawai, Takafumi Ueda, (unknown), (unknown), (unknown), (unknown), Akinobu Hamada, Akihiko Yoshida, Akihiro Hirakawa, Taro Shibata, Kenichi Nakamura, Kan Yonemori	2
2	Dietary vanillic acid prevents postmenopausal symptoms in ovariectomized mice 2023 ·Food Science and Technology Research ·(unknown), (unknown), Takashi Fukuda, Masashi Ando, Norifumi Shirasaka, Yoshimi Homma	0
3	O9-1 Paclitaxel plus cetuximab vs. nivolumab for patients with platinum-refractory recurrent/metastatic head and neck cancer 2023 ·Annals of Oncology ·Hiroyuki Kodama, Shigenori Kadowaki, (unknown), (unknown), (unknown), (unknown), Takatsugu Ogata, Yuki Matsubara, Kazunori Honda, Toshiki Masuishi, Yukiya Narita, (unknown), Masashi Ando, Nobuhiro Hanai, Kei Muro	0
4	Current state of therapeutic development for rare cancers in Japan, and proposals for improvement 2018 ·Cancer Science ·Akira Kawai, Toshio Goto, Tatsuhiro Shibata, Kenzaburo Tani, Shuki Mizutani, Akiyoshi Nishikawa, Taro Shibata, Seiichi Matsumoto, Kyosuke Nagata, Mamoru Narukawa, Shigeyuki Matsui, Masashi Ando, Junya Toguchida, Morito Monden, Toshio Heike, Shinya Kimura, Ryuzo Ueda	9
5	Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody 2017 ·Oncology ·Hiroko Hasegawa, Hiroya Taniguchi, Seiichiro Mitani, Toshiki Masuishi, Azusa Komori, Yukiya Narita, Shigenori Kadowaki, Takashi Ura, Masashi Ando, Yasushi Yatabe, Kei Muro	6
6	169P Serum CA19-9 response is an early predictive marker for the efficacy of regorafenib in refractory metastatic colorectal cancer 2015 ·Annals of Oncology ·(unknown), Hiroya Taniguchi, Yosuke Kito, Satoshi Hamauchi, Toshiki Masuishi, Hiroko Hasegawa, Seiichiro Mitani, Yukiya Narita, Shigenori Kadowaki, Takashi Ura, Masashi Ando, Keita Mori, Hirofumi Yasui, Kei Muro, Kentaro Yamazaki	0
7	Efficacy of everolimus, a novel mTOR inhibitor, against basal‐like triple‐negative breast cancer cells 2012 ·Cancer Science ·Mayu Yunokawa, Fumiaki Koizumi, Yuka Kitamura, Yasufumi Katanasaka, Naoko Okamoto, Makoto Kodaira, Kan Yonemori, Chikako Shimizu, Masashi Ando, Kenkichi Masutomi, Teruhiko Yoshida, Yasuhiro Fujiwara, Kenji Tamura	86
8	Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer 2011 ·Breast Cancer Research and Treatment ·Makiko Ono, Hitoshi Tsuda, Chikako Shimizu, Sohei Yamamoto, Tatsuhiro Shibata, Harukaze Yamamoto, Taizo Hirata, Kan Yonemori, Masashi Ando, Kenji Tamura, Noriyuki Katsumata, Takayuki Kinoshita, Yuichi Takiguchi, Hideki Tanzawa, Yasuhiro Fujiwara	245
9	Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD). 2010 ·PubMed ·Hiroshi Shigematsu, Toshiya Nishibe, Yukio Obitsu, Kentaro Matsuzaki, Akimasa Ishida, Tomohiro Miyata, Shunya Shindo, (unknown), Takashi Ohta, Masashi Ando, Tomio Kawasaki, (unknown), (unknown)	12
10	Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy 2010 ·British Journal of Cancer ·Maki Tanioka, Carlos Shimizu, Kan Yonemori, Kenichi Yoshimura, Kenji Tamura, T. Kouno, Masashi Ando, Noriyuki Katsumata, Hitoshi Tsuda, (unknown), Yasuhiro Fujiwara	44
11	Immunohistochemical expression of HER1, HER3, and HER4 in HER2‐positive breast cancer patients treated with trastuzumab‐containing neoadjuvant chemotherapy 2010 ·Journal of Surgical Oncology ·Kan Yonemori, Koji Tsuta, Chikako Shimizu, Yutaka Hatanaka, Akihiro Hirakawa, Makiko Ono, Tsutomu Kouno, Noriyuki Katsumata, Masashi Ando, Kenji Tamura, Tadashi Hasegawa, Takayuki Kinoshita, Yasuhiro Fujiwara	17
12	A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer 2010 ·Medical Oncology ·Kenji Hashimoto, Kan Yonemori, Chikako Shimizu, Akihiro Hirakawa, Harukaze Yamamoto, Makiko Ono, Taizo Hirata, Tsutomu Kouno, Kenji Tamura, Noriyuki Katsumata, Masashi Ando, Yasuhiro Fujiwara	3
13	Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy 2010 ·Cancer Chemotherapy and Pharmacology ·Maki Tanioka, Noriyuki Katsumata, Kan Yonemori, Tsutomu Kouno, Chikako Shimizu, Kenji Tamura, Masashi Ando, Yasuhiro Fujiwara	14
14	Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer 2009 ·International Journal of Clinical Oncology ·Makiko Ono, Masashi Ando, Mayu Yunokawa, Eriko Nakano, Kan Yonemori, Koji Matsumoto, Tsutomu Kouno, Chikako Shimizu, Kenji Tamura, Noriyuki Katsumata, Yasuhiro Fujiwara	30
15	Long-term Outcome and Pattern of Relapse after Neoadjuvant Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 2-positive Primary Breast Cancer 2009 ·Japanese Journal of Clinical Oncology ·Chikako Shimizu, (unknown), Kenichi Yoshimura, Hitoshi Tsuda, Maria Piera Mano, Masashi Ando, Kenji Tamura, Yasuhiro Fujiwara	14
16	Therapy-Related Acute Promyelocytic Leukemia Caused by Hormonal Therapy and Radiation in a Patient with Recurrent Breast Cancer 2008 ·Japanese Journal of Clinical Oncology ·Makiko Ono, Takuji Watanabe, Carlos Shimizu, Nobuhiro Hiramoto, Yukinobu Goto, Kan Yonemori, (unknown), Masashi Ando, Kenji Tamura, (unknown), Yasuhiro Fujiwara	8
17	Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy 2006 ·Breast Cancer Research and Treatment ·Kan Yonemori, Noriyuki Katsumata, Masayuki Kaneko, Hajime Uno, Koji Matsumoto, Tsutomu Kouno, Chikako Shimizu, Masashi Ando, Masahiro Takeuchi, Yasuhiro Fujiwara	3
18	Bronchial Hyperreactivity in Patients With Familial Amyloidotic Polyneuropathy and Autonomic Neuropathy 1997 ·American Journal of Respiratory and Critical Care Medicine ·Osamu Kawano, Hirotsugu Kohrogi, Yukio Ando, Hajime Iwagoe, Kenichi Fujii, Junji Hamamoto, Takanori Yamaguchi, Hiroaki Okabe, Masashi Ando	1
19	460 Contribution of embryo-derived platelet activating factor in pregnancy establishment in mice : a study with a PAF antagonist, CV-6209. : 1989 ·日本産科婦人科學會雜誌 ·Masashi Ando, H. Suginami, Shinya Matsuura	1
20	Regulation of HCL secretion in the eel stomach 1986 ·ZOOLOGICAL SCIENCE ·Masashi Ando, T. Hirayáma, (unknown), Masayuki Kobayashi	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact